Gilead Sciences, Inc. is a top AI-powered biotech stock to buy now, leading in antiviral and oncology therapies with a focus on precision medicine and global patient access under CEO Daniel O’Day. The company broke ground on a new AI-enabled Pharmaceutical Development and Manufacturing Center to enhance biologics production and technology transfer.

The facility will streamline biologics production with AI integration, reflecting a trend towards AI-powered efficiency and innovation in therapies like CAR-T treatments and antivirals. Gilead Sciences, Inc. is expanding its global health impact through partnerships for HIV prevention in low- and lower-middle-income countries, reinforcing its commitment to broadening access to life-saving treatments.

While Gilead Sciences, Inc. shows promise as an investment, other AI stocks may offer greater upside potential with less downside risk. For those seeking an undervalued AI stock benefiting from current economic trends, check out the best short-term AI stock for potential growth opportunities.

Read more at Yahoo Finance: Gilead Sciences, Inc. (GILD) Expands U.S. Manufacturing Capacity With $32B Investment Through 2030